Source: Clinical Lab Products

Pivotal: Pivotal to Provide Clinical Research Services to Lucid Diagnostics for Its Clinical Studies of EsoGuard and EsoCheck for Diagnosis of Barrett's Esophagus

Two multinational, multicenter clinical studies have been launched to support FDA clearance of EsoGuard and EsoCheck as in vitro diagnostics.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Ibrahim Farr's photo - Chairman & CEO of Pivotal SL

Chairman & CEO

Ibrahim Farr

CEO Approval Rating

90/100

Read more